Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03115541 · ClinicalTrials.gov registry record
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
A clinical trial, sponsored by McMaster University.
- Completed
- Registry status
- 187
- Enrollment target
NCT03115541: Completed study, sponsored by McMaster University.
NCT03115541 is a clinical trial that has completed, run by McMaster University. The registered enrollment target is 187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03115541 has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the incidence of post-operative venous thromboembolism (VTE) in patients undergoing major esophageal resection for malignancy.
Primary Outcome
CT pulmonary angiogram and bilateral leg Doppler ultrasound to assess evidence of PE/DVT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2020-09-01 |
What the finished NCT03115541 record still lists
NCT03115541 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03115541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03115541 about?
NCT03115541 is a clinical study titled "Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection". The purpose of this study is to determine the incidence of post-operative venous thromboembolism (VTE) in patients undergoing major esophageal resection for malignancy.
What is the current status of trial NCT03115541?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2017-07-10. Estimated completion is 2020-09-01.
Who is sponsoring clinical trial NCT03115541?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI